Find out whether you should get the RSV vaccine, known as Abrysvo, during pregnancy and when it's recommended.

Thousands of premature babies in the UK can now be protected against a common winter virus which can cause a dangerous lung ...

The FDA had previously approved Pfizer's Abrysvo vaccine only for use in older adults. Adults ages 60 and older are recommended to talk to their doctors about potentially getting the shot.

Abrysvo is made by Pfizer. The Food and Drug Administration (FDA) has approved the first vaccine for pregnant women to prevent RSV in infants, the agency announced on Monday.

Public health minister Jenni Minto said the jab would be available for babies born before 32 weeks to protect them over the ...

The UK's medicines regulator has warned NHS healthcare staff about an increased risk of a condition affecting the nerves in ...

The eight new ACIP members met for the first time June 25 after Kennedy fired all 17 original members of the committee June 9 ...

U.S. FDA Approves ABRYSVO™, Pfizer’s Vaccine for the Prevention of Respiratory Syncytial Virus (RSV) in Infants Through Active Immunization of Pregnant Individuals 32-36 Weeks of Gestational Age ...

Abrysvo, Pfizer’s vaccine now approved for pregnancy, and another RSV vaccine manufactured by GSK have recently been approved for adults age 60 and older.

In clinical trials where ABRYSVO was compared to placebo, infants born to pregnant individuals experienced low birth weight (5.1% ABRYSVO versus 4.4% placebo) and jaundice (7.2% ABRYSVO versus 6.7 ...

Abrysvo was also approved by the FDA in May 2023 to prevent RSV illness in adults 60 years and older. There are now tools available to protect the most vulnerable members of the population ...

Pfizer Inc. today announced positive top-line safety and immunogenicity results from substudy B of the ongoing pivotal Phase 3 clinical trial MONeT, evaluating two doses of ABRYSVO vaccine in ...